1. Presented By James Rubenstein at 2016 ASCO Annual Meeting
<br /><br />Phase I Investigation of Lenalidomide plus Rituximab and Outcomes of Lenalidomide Maintenance in Recurrent CNS Lymphoma
Presented By James Rubenstein at 2016 ASCO Annual Meeting

2. Presented By James Rubenstein at 2016 ASCO Annual Meeting
Key Questions
Presented By James Rubenstein at 2016 ASCO Annual Meeting

3. Presented By James Rubenstein at 2016 ASCO Annual Meeting
Slide 3
Presented By James Rubenstein at 2016 ASCO Annual Meeting

4. Presented By James Rubenstein at 2016 ASCO Annual Meeting
Slide 4
Presented By James Rubenstein at 2016 ASCO Annual Meeting

5. Presented By James Rubenstein at 2016 ASCO Annual Meeting
Slide 5
Presented By James Rubenstein at 2016 ASCO Annual Meeting

6. Presented By James Rubenstein at 2016 ASCO Annual Meeting
Slide 6
Presented By James Rubenstein at 2016 ASCO Annual Meeting

7. Presented By James Rubenstein at 2016 ASCO Annual Meeting
Slide 7
Presented By James Rubenstein at 2016 ASCO Annual Meeting

8. Presented By James Rubenstein at 2016 ASCO Annual Meeting
Slide 8
Presented By James Rubenstein at 2016 ASCO Annual Meeting

9. Presented By James Rubenstein at 2016 ASCO Annual Meeting
<br /><br /><br /><br />A Phase I Study of Lenalidomide Plus Rituximab for Recurrent/Refractory <br />Central Nervous System <br />and Intraocular Lymphoma<br /><br /><br />RV-NHL-PI-0682<br />
Presented By James Rubenstein at 2016 ASCO Annual Meeting

10. Presented By James Rubenstein at 2016 ASCO Annual Meeting
Slide 10
Presented By James Rubenstein at 2016 ASCO Annual Meeting

11. Presented By James Rubenstein at 2016 ASCO Annual Meeting
Slide 11
Presented By James Rubenstein at 2016 ASCO Annual Meeting

12. Presented By James Rubenstein at 2016 ASCO Annual Meeting
Slide 12
Presented By James Rubenstein at 2016 ASCO Annual Meeting

13. Presented By James Rubenstein at 2016 ASCO Annual Meeting
Slide 13
Presented By James Rubenstein at 2016 ASCO Annual Meeting

14. Presented By James Rubenstein at 2016 ASCO Annual Meeting
Slide 14
Presented By James Rubenstein at 2016 ASCO Annual Meeting

15. Presented By James Rubenstein at 2016 ASCO Annual Meeting
Slide 15
Presented By James Rubenstein at 2016 ASCO Annual Meeting

16. Presented By James Rubenstein at 2016 ASCO Annual Meeting
Slide 16
Presented By James Rubenstein at 2016 ASCO Annual Meeting

17. Brain Parenchymal Response<br />(20 mg Lenalidomide)
Presented By James Rubenstein at 2016 ASCO Annual Meeting

18. Presented By James Rubenstein at 2016 ASCO Annual Meeting
Slide 18
Presented By James Rubenstein at 2016 ASCO Annual Meeting

19. Presented By James Rubenstein at 2016 ASCO Annual Meeting
Slide 19
Presented By James Rubenstein at 2016 ASCO Annual Meeting

20. Presented By James Rubenstein at 2016 ASCO Annual Meeting
Slide 20
Presented By James Rubenstein at 2016 ASCO Annual Meeting

21. Presented By James Rubenstein at 2016 ASCO Annual Meeting
Slide 21
Presented By James Rubenstein at 2016 ASCO Annual Meeting

22. Presented By James Rubenstein at 2016 ASCO Annual Meeting
Slide 22
Presented By James Rubenstein at 2016 ASCO Annual Meeting

23. Presented By James Rubenstein at 2016 ASCO Annual Meeting
Slide 23
Presented By James Rubenstein at 2016 ASCO Annual Meeting

24. Presented By James Rubenstein at 2016 ASCO Annual Meeting
Slide 24
Presented By James Rubenstein at 2016 ASCO Annual Meeting

25. Presented By James Rubenstein at 2016 ASCO Annual Meeting
Slide 25
Presented By James Rubenstein at 2016 ASCO Annual Meeting

26. Presented By James Rubenstein at 2016 ASCO Annual Meeting
<br /><br />Retrospective Analysis of Maintenance After Salvage Therapy in Recurrent Disease
Presented By James Rubenstein at 2016 ASCO Annual Meeting

27. Presented By James Rubenstein at 2016 ASCO Annual Meeting
Slide 27
Presented By James Rubenstein at 2016 ASCO Annual Meeting

28. Presented By James Rubenstein at 2016 ASCO Annual Meeting
Slide 28
Presented By James Rubenstein at 2016 ASCO Annual Meeting

29. Presented By James Rubenstein at 2016 ASCO Annual Meeting
Slide 29
Presented By James Rubenstein at 2016 ASCO Annual Meeting

30. Presented By James Rubenstein at 2016 ASCO Annual Meeting
Slide 30
Presented By James Rubenstein at 2016 ASCO Annual Meeting

31. Presented By James Rubenstein at 2016 ASCO Annual Meeting
Slide 31
Presented By James Rubenstein at 2016 ASCO Annual Meeting